Catalyst Pharmaceutical CPRX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's accounts payable?
- Catalyst Pharmaceutical (CPRX) reported accounts payable of $7.15M in Q1 2026.
- How has Catalyst Pharmaceutical's accounts payable changed year-over-year?
- Catalyst Pharmaceutical's accounts payable decreased by 36.1% year-over-year, from $11.2M to $7.15M.
- What is the long-term trend for Catalyst Pharmaceutical's accounts payable?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's accounts payable has grown at a 21.4% compound annual growth rate (CAGR), from $4.26M to $11.2M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.